Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-13

FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. The approval covers the changes ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE)